“The law requires that patented inventions are available to the public at affordable prices as well as obligates the patent holders to work their patents in India.
“By making use of flexibilities in the TRIPS agreement the Indian Patents Act and policy reduce options to pharmaceutical companies, be they Indian or foreign, to profit from diseases or those suffering from them.”
via Will Modi bow to US pressure to modify India’s pro-people patent law? – The Times of India.
News links 